Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364
- PMID: 35328161
- PMCID: PMC8947690
- DOI: 10.3390/diagnostics12030608
Comment on Li et al. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics 2021, 11, 2364
Abstract
In 2021, Li et al. published an article on BDP1 variants and implications in pediatric neuroblastoma patients [...].
Conflict of interest statement
The author declares no conflict of interest.
Comment on
- Diagnostics (Basel). 11:2364.
References
-
- Li X., Sun L., Stucky A., Tu L., Cai J., Chen X., Wu Z., Jiang X., Li S.C. BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. Diagnostics. 2021;11:2364. doi: 10.3390/diagnostics11122364. - DOI - PMC - PubMed
-
- Kim Y.W., Wang H., Sures I., Lammers R., Martell K.J., Ullrich A. Characterization of the PEST family protein tyrosine phosphatase BDP1. Oncogene. 1996;13:2275–2279. - PubMed
LinkOut - more resources
Full Text Sources
